Patents by Inventor Wenyun Zhou

Wenyun Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR EFFICIENTLY ACTIVATING AND EXPANDING T CELLS
    Publication number: 20210032337
    Abstract: The present invention discloses that T cells can be efficiently activated and expanded by a simple monomeric single chain bispecific antibody without using complicated beads, accessory cells, antibody-coating plates, or tetrameric antibody complex. The present invention also discloses that T cells activated and expanded by the monomeric single chain bispecific antibody can be efficiently transduced by virus.
    Type: Application
    Filed: August 4, 2019
    Publication date: February 4, 2021
    Inventor: Wenyun Zhou
  • P14.7 protein and uses thereof as vaccine adjuvant
    Patent number: 10525127
    Abstract: The present invention Provides composition and method for stimulating immune responses against antigens without using conventional adjuvants (such as aluminum salt adjuvants, oil-in-water emulsion adjuvants, toll-like receptor agonist adjuvants, and the like). The composition contains p14.7 protein and an antigen to which the stimulated illumine responses are desired. The p14.7 protein functions as an adjuvant so that the immune responses to the antigen stimulated by the composition comprising p14.7 protein and the antigen are greater than the immune responses stimulated by the antigen alone. The current invention also provides a method for producing thermostable vaccines and a simple strategy for avoiding vaccine cold-chain maintenance by lyophilization.
    Type: Grant
    Filed: March 31, 2018
    Date of Patent: January 7, 2020
    Assignee: Femtomab
    Inventor: Wenyun Zhou
  • P14.7 PROTEIN AND USES THEREOF AS VACCINE ADJUVANT
    Publication number: 20190298823
    Abstract: The present invention Provides composition and method for stimulating immune responses against antigens without using conventional adjuvants (such as aluminum salt adjuvants, oil-in-water emulsion adjuvants, toll-like receptor agonist adjuvants, and the like). The composition contains p14.7 protein and an antigen to which the stimulated illumine responses are desired. The p14.7 protein functions as an adjuvant so that the immune responses to the antigen stimulated by the composition comprising p14.7 protein and the antigen are greater than the immune responses stimulated by the antigen alone. The current invention also provides a method for producing thermostable vaccines and a simple strategy for avoiding vaccine cold-chain maintenance by lyophilization.
    Type: Application
    Filed: March 31, 2018
    Publication date: October 3, 2019
    Inventor: Wenyun Zhou